INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 188 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $984,553 | -90.2% | 18,901 | -88.1% | 0.00% | -100.0% |
| Q2 2023 | $10,052,113 | +72.5% | 158,751 | +47.5% | 0.00% | +50.0% |
| Q1 2023 | $5,828,652 | +51.4% | 107,639 | +48.0% | 0.00% | 0.0% |
| Q4 2022 | $3,848,660 | -12.5% | 72,726 | -23.0% | 0.00% | 0.0% |
| Q3 2022 | $4,396,000 | +187.9% | 94,480 | +253.2% | 0.00% | +100.0% |
| Q2 2022 | $1,527,000 | -82.4% | 26,751 | -81.1% | 0.00% | -66.7% |
| Q1 2022 | $8,661,000 | -18.1% | 141,550 | -29.9% | 0.00% | -25.0% |
| Q4 2021 | $10,571,000 | +273.4% | 201,965 | +166.0% | 0.00% | +300.0% |
| Q3 2021 | $2,831,000 | +17.7% | 75,933 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $2,406,000 | +90.0% | 58,957 | +58.1% | 0.00% | – |
| Q1 2021 | $1,266,000 | -73.8% | 37,290 | -75.5% | 0.00% | -100.0% |
| Q4 2020 | $4,839,000 | -24.6% | 152,153 | -39.1% | 0.00% | -50.0% |
| Q3 2020 | $6,414,000 | -65.1% | 249,957 | -65.1% | 0.00% | -69.2% |
| Q2 2020 | $18,399,000 | +2578.2% | 716,731 | +1503.0% | 0.01% | – |
| Q1 2020 | $687,000 | -93.9% | 44,711 | -86.5% | 0.00% | -100.0% |
| Q4 2019 | $11,323,000 | +1703.0% | 330,025 | +729.6% | 0.02% | +700.0% |
| Q3 2017 | $628,000 | -35.6% | 39,780 | -33.7% | 0.00% | -60.0% |
| Q1 2017 | $975,000 | +418.6% | 59,976 | +381.1% | 0.01% | +400.0% |
| Q4 2016 | $188,000 | -68.5% | 12,467 | -68.1% | 0.00% | -66.7% |
| Q3 2016 | $596,000 | +124.1% | 39,100 | +690.5% | 0.00% | +50.0% |
| Q4 2015 | $266,000 | -62.3% | 4,946 | -71.9% | 0.00% | -50.0% |
| Q3 2015 | $705,000 | +281.1% | 17,617 | +60.2% | 0.00% | +100.0% |
| Q2 2014 | $185,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |